About Pazopanib hydrochloride 433.4mg Equivalent to Pazopanib
            
            Class: | Tyrosine kinase inhibitor  
Use: | Treatment of advanced renal cell carcinoma (RCC) and soft tissue sarcoma (STS)  
Adult dose: | 800 mg orally once daily, taken without food (at least 1 hour before or 2 hours after a meal)  
Pediatric dose: | Safety and efficacy not established in pediatric patients  
Side effects: | Diarrhea, hypertension, nausea, fatigue, vomiting, anorexia, liver enzyme elevations, rash  
Contraindications: | Hypersensitivity to pazopanib or any component of the for
         
        
            
                
                
                    
                        Drug Class
                    
                    Tyrosine kinase inhibitor
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of advanced renal cell carcinoma (RCC) and soft tissue sarcoma (STS)
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (20°C to 25°C or 68°F to 77°F); protect from moisture and light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: NOVARTIS PHARMA AG [Basel-Switzerland], Switzerland
                    
                    
                    Package Size
                    30's HDPE Bottle
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 7667.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        800 mg orally once daily, taken without food (at least 1 hour before or 2 hours after a meal)
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients
                    
                 
                
                
                    
                        Side Effects
                    
                    Diarrhea, hypertension, nausea, fatigue, vomiting, anorexia, liver enzyme elevations, rash
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to pazopanib or any component of the formulation; severe hepatic impairment (Child-Pugh Class C)
         
        
        
            
                Important Warnings
            
            Risk of hepatotoxicity, QT interval prolongation, gastrointestinal perforation, and severe hypertension; monitor liver function tests and blood pressure regularly during treatment
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.